Literature DB >> 17185068

Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions.

Glenn T Clark1, Saravanan Ram.   

Abstract

This article reviews four of the involuntary hyperkinetic motor disorders that affect the orofacial region: bruxism, orofacial dystonia, oromandibular dyskinesia, and medication-induced extrapyramidal syndrome-dystonic reactions. It discusses and contrasts the clinical features and management strategies for spontaneous, primary, and drug-induced motor disorders in the orofacial region. The article provides a list of medications that have been reported to cause drug-related extrapyramidal motor activity, and discusses briefly the genetic and traumatic events that are associated with spontaneous dystonia. Finally, it presents an approach for management of the orofacial motor disorders. The contraindications, side effects, and usual approach for medications and injections are covered. An overview of the indications, contraindications, and complications of using botulinum toxin as a therapeutic modality is discussed briefly.

Entities:  

Mesh:

Year:  2007        PMID: 17185068     DOI: 10.1016/j.cden.2006.09.002

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  12 in total

1.  Buspirone use in the treatment of atomoxetine-induced bruxism.

Authors:  Murat Yüce; Koray Karabekiroğlu; Gökçe Nur Say; Mahmut Müjdeci; Meral Oran
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-11-09       Impact factor: 2.576

2.  Associations among masticatory muscle activity, physical activity and self-reported oral behaviours in adult women.

Authors:  Sabarinath Prasad; Divya Ramanan; Hamza Bennani; Michael Paulin; Richard D Cannon; Sandro Palla; Mauro Farella
Journal:  Clin Oral Investig       Date:  2021-02-06       Impact factor: 3.573

3.  Effectiveness of botulinum toxin type A treatment of neck pain related to nocturnal bruxism: a case report.

Authors:  Andrea Santamato; Francesco Panza; Daniela Di Venere; Vincenzo Solfrizzi; Vincenza Frisardi; Maurizio Ranieri; Pietro Fiore
Journal:  J Chiropr Med       Date:  2010-09

Review 4.  Movement disorders of the mouth: a review of the common phenomenologies.

Authors:  C M Ghadery; L V Kalia; B S Connolly
Journal:  J Neurol       Date:  2022-07-29       Impact factor: 6.682

5.  Treating bipolar disorder in the primary care setting: the role of aripiprazole.

Authors:  J Sloan Manning; Susan L McElroy
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

6.  Childhood Trauma, Quality of Life, Sleep Quality, Anxiety and Depression Levels in People with Bruxism.

Authors:  İbrahim Yağci; Yasin Taşdelen; Yüksel Kivrak
Journal:  Noro Psikiyatr Ars       Date:  2020-03-02       Impact factor: 1.339

7.  Middle ear myoclonus: two informative cases and a systematic discussion of myogenic tinnitus.

Authors:  Aviva Ellenstein; Nadia Yusuf; Mark Hallett
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-04-15

Review 8.  The use of botulinum toxin in head and face medicine: an interdisciplinary field.

Authors:  Rainer Laskawi
Journal:  Head Face Med       Date:  2008-03-10       Impact factor: 2.151

9.  Current Treatments of Bruxism.

Authors:  Marc Guaita; Birgit Högl
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

10.  A Study on Drug-Induced Tardive Dyskinesia: Orofacial Musculature Involvement and Patient's Awareness.

Authors:  Arunachalam M Anusa; Rooban Thavarajah; Dinesh Nayak; Elizabeth Joshua; Umadevi Krishnamohan Rao; Kannan Ranganathan
Journal:  J Orofac Sci       Date:  2019-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.